Dr Ashleys Limited infuses academic researchers on Board, inducts top strategists in Advisory Board

One of Europes’s Most renowned Economist Prof Dr Nina, Director, Director of Department of Economics at The Latvian Acadamy of Sciences and AS Lights Director Mr Gerhald to guide HOPSTEDTER 

Hong Kong, May 4:  Dr Ashleys Limited , the Hong Kong based pharmaceutical Company today announced the induction of noted & eminent global researchers as advisors to the board of directors. Europes’s most renowned Economist Prof Dr Nina Linde, ,  Director of Department of Economics at The Latvian Acadamy of Sciences  and  AS Lights Director Mr Gerhald  Hopstedter will be guiding & advising the  Dr Ashleys Limited’s Board of Directors in building  the company as a strong international pharmaceutical company in its pursuit to its mission to widen its academic excellence.

Announcing the appointment of two seasoned academic researchers as Advisors, {Prof} Dr. Kannan Vishwanatth, Managing Director of Dr Ashleys Limited said “We are pleased to announce Dr Nina Linde and Mr Mr Gerhald Hopstedter on our Board. We can’t wait to see how our highly experienced board members will enlighten us to develop the vision and purpose of building Dr Ashleys in the market by advising on matters of strategic importance, leverage decades of top-tier industry experience, broaden and deepen our relationships, and ensure continued growth and success.

Dr Nina Linde has broad leadership experience in corporate management and academia. She is an international speaker recognized by peers, executives, and students with numerous awards for her innovative leadership and passion for teaching. She inspires students from both business and engineering disciplines in his courses for open innovation, business models, smart cities, scalable smart villages, and business models for emerging economies…

Before joining the academy of Sciences Latvia Dr Linde has been the Advisor to Ministry of education in Latvia, Mr Gerhald Hopstedter is a noted author & research analyst. Dr Satya is the founder chairman of AS Lights and Balticsmagazine, Baltics states  most acclaimed research firm engaged in timely, in-depth analysis of companies, industries, markets, and world economies. Mr Gerhald Hopstedter is also the author of many top books Mr Gerhald is most respected & distinguished entrepreneur & known for championing the cause of Citizen’s rights & free speech.

Dr Ashleys Limited is a research-focused vertically integrated pharmaceutical Company, which Contract manufactures active pharmaceutical ingredients and is in contract research and manufacturing services (CRAMS). The Company is a market leader in the Antimalarial API segment and is the world’s third-largest contract manufacturer of Quinine salts. It also exports its products to more than 60 emerging countries in Africa, Central and South America, and Asia.

Business

Mealawe Secures USD 1 Million in Funding to Revolutionize Daily Food Delivery Across India

Pune (Maharashtra) [India], February 06: Mealawe, a pioneering food-tech company, has raised $1 million in funding from a mix of Foreign Direct Investment (FDI), a network of Shark Tank founders, and angel investors associated with companies such as Goldman Sachs and Oracle. This funding will drive the company’s expansion into 14 cities over the next […]

Read More
Business

SRK sets new sustainability benchmarks with industry-leading carbon reduction

Surat (Gujarat) [India], February 06: Shree Ramkrishna Exports (SRK), a global leader in natural diamond crafting and exports, has set a new benchmark in sustainability by achieving a 34% reduction in greenhouse gas (GHG) emissions per carat compared to the global industry average. This achievement, announced on International Reducing CO2 Emissions Day, which is celebrated […]

Read More
Business

Budget 2025: Industry Voices Weigh in on Growth, Relief, and Challenges

New Delhi [India], February 4: The wait is over, and the numbers are in. Finance Minister Nirmala Sitharaman has presented the Union Budget 2025, and now the real analysis begins. Across boardrooms and startup hubs, industry leaders are dissecting the budget’s details, assessing its potential to shape the economic landscape. Here’s a snapshot of what […]

Read More